{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:29:49Z","timestamp":1750937389219,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12282-022-01360-2","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T18:26:23Z","timestamp":1654021583000},"page":"808-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Significance of prostate\/pancreatic\/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1926-2927","authenticated-orcid":false,"given":"Yuko","family":"Minoura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-9598","authenticated-orcid":false,"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanae","family":"Tachikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-416X","authenticated-orcid":false,"given":"Nobumoto","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9115-7980","authenticated-orcid":false,"given":"Kenichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4413-8701","authenticated-orcid":false,"given":"Akihiro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the us preventive services task force. JAMA. 2019;322:666\u201385.","journal-title":"JAMA"},{"key":"1360_CR2","unstructured":"Pilarski R. The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families."},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2017.74.1173","volume":"36","author":"VN Giri","year":"2018","unstructured":"Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, et al. Role of genetic testing for inherited prostate cancer risk: philadelphia prostate cancer consensus conference 2017. J Clin Oncol. 2018;36:414\u201324.","journal-title":"J Clin Oncol"},{"key":"1360_CR4","doi-asserted-by":"crossref","unstructured":"Silvestri V, Leslie G, Barnes DR, Group C, Agnarsson BA, Aittomaki K, et al. Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA). JAMA Oncol. 2020; 6: 1218\u201330.","DOI":"10.1001\/jamaoncol.2020.2134"},{"key":"1360_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103033","volume":"60","author":"K Mizukami","year":"2020","unstructured":"Mizukami K, Iwasaki Y, Kawakami E, Hirata M, Kamatani Y, Matsuda K, et al. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes. EBioMedicine. 2020;60: 103033.","journal-title":"EBioMedicine"},{"key":"1360_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/cup.13689","volume":"47","author":"A Toussi","year":"2020","unstructured":"Toussi A, Mans N, Welborn J, Kiuru M. Germline mutations predisposing to melanoma. J Cutan Pathol. 2020;47:606\u201316.","journal-title":"J Cutan Pathol"},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10689-010-9377-y","volume":"9","author":"OM Ginsburg","year":"2010","unstructured":"Ginsburg OM, Kim-Sing C, Foulkes WD, Ghadirian P, Lynch HT, Sun P, et al. BRCA1 and BRCA2 families and the risk of skin cancer. Fam Cancer. 2010;9:489\u201393.","journal-title":"Fam Cancer"},{"key":"1360_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/bjd.13626","volume":"172","author":"PV Gumaste","year":"2015","unstructured":"Gumaste PV, Penn LA, Cymerman RM, Kirchhoff T, Polsky D, McLellan B. Skin cancer risk in BRCA1\/2 mutation carriers. Br J Dermatol. 2015;172:1498\u2013506.","journal-title":"Br J Dermatol"},{"key":"1360_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-017-9661-5","volume":"36","author":"SA Leachman","year":"2017","unstructured":"Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, et al. Identification, genetic testing, and management of hereditary melanoma. Cancer Metastasis Rev. 2017;36:77\u201390.","journal-title":"Cancer Metastasis Rev"},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/CMAR.S189627","volume":"11","author":"C Forbes","year":"2019","unstructured":"Forbes C, Fayter D, de Kock S, Quek RG. A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer. Cancer Manag Res. 2019;11:2321\u201337.","journal-title":"Cancer Manag Res"},{"key":"1360_CR11","doi-asserted-by":"crossref","unstructured":"Angeli D, Salvi S, Tedaldi G. Genetic predisposition to breast and ovarian cancers: how many and which genes to test? Int J Mol Sci. 2020; 21.","DOI":"10.3390\/ijms21031128"},{"key":"1360_CR12","doi-asserted-by":"crossref","unstructured":"Hereditary Cancer Syndromes and Risk Assessment: Acog Committee Opinion, Number 793. Obstet Gynecol 2019; 134(6): e143\u2013e9.","DOI":"10.1097\/AOG.0000000000003562"},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transp. 2013;48:452\u20138.","journal-title":"Bone Marrow Transp"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol. 2002;20:1480\u201390.","journal-title":"J Clin Oncol"},{"key":"1360_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol. 2006;24:707\u201315.","journal-title":"J Clin Oncol"},{"key":"1360_CR16","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002;20:2701\u201312.","journal-title":"J Clin Oncol"},{"key":"1360_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/jhg.2015.164","volume":"61","author":"E Kang","year":"2016","unstructured":"Kang E, Park SK, Lee JW, Kim Z, Noh WC, Jung Y, et al. KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Hum Genet. 2016;61:365\u201371.","journal-title":"J Hum Genet"},{"key":"1360_CR18","doi-asserted-by":"crossref","unstructured":"Junejo NN, AlKhateeb SS. BRCA2 gene mutation and prostate cancer risk. Comprehensive review and update. Saudi Med J. 2020; 41: 9\u201317.","DOI":"10.15537\/smj.2020.1.24759"},{"key":"1360_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","volume":"17","author":"DB Zhen","year":"2015","unstructured":"Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17:569\u201377.","journal-title":"Genet Med"},{"key":"1360_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/EDBK_238977","volume":"39","author":"R Pilarski","year":"2019","unstructured":"Pilarski R. The role of BRCA testing in hereditary pancreatic and prostate cancer families. Am Soc Clin Oncol Educ Book. 2019;39:79\u201386.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"1360_CR21","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.","journal-title":"Nat Commun"},{"key":"1360_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.eururo.2019.08.025","volume":"77","author":"T Nyberg","year":"2020","unstructured":"Nyberg T, Frost D, Barrowdale D, Evans DG, Bancroft E, Adlard J, et al. Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Eur Urol. 2020;77:24\u201335.","journal-title":"Eur Urol"},{"key":"1360_CR23","doi-asserted-by":"crossref","unstructured":"Abida W, Armenia J, Gopalan A, Brennan R, Walsh M, Barron D, et al. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making. JCO Precis Oncol. 2017; 2017.","DOI":"10.1200\/PO.17.00029"},{"key":"1360_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"The Breast Cancer Linkage Consortium","year":"1999","unstructured":"The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91:1310\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"1360_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","volume":"35","author":"O Johannsson","year":"1999","unstructured":"Johannsson O, Loman N, M\u00f6ller T, Kristoffersson U, Borg A, Olsson H. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer. 1999;35:1248\u201357.","journal-title":"Eur J Cancer"},{"key":"1360_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","volume":"11","author":"A Moran","year":"2012","unstructured":"Moran A, O\u2019Hara C, Khan S, Shack L, Woodward E, Maher ER, et al. Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Fam Cancer. 2012;11:235\u201342.","journal-title":"Fam Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01360-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T16:08:05Z","timestamp":1660752485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01360-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01360-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"type":"print","value":"1340-6868"},{"type":"electronic","value":"1880-4233"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Masato Takahashi and Akihiro Sakurai received honorarium (lecture fee) from AstraZeneca K.K.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}